November saw a sharp rebound in both bonds and equities. Expectations of a soft landing have become entrenched as falling inflation encourages markets to dream.
In this week's podcast, Nucleus Wealth's Chief Economist, Leith Van Onselen, and Head of Advice, Samuel Kerr, delve into the Australian property market. Will interest rates fall, and prices will continue to rise? Is the huge immigration policy going to push prices higher, or will prices stagnate ...
Australian energy prices present a paradox. Australia is one of the largest coal and liquefied natural gas exporters on the planet. However, Australia also has some of the best solar resources in the world. So why are energy prices high here while tumbling elsewhere? In this week’s podcast, Nucleus ...
In this week’s podcast, Nucleus Wealth’s Chief Investment Officer, Damien Klassen and Head of Advice, Samuel Kerr explore the most exciting investment themes set to redefine the next few years. We're talking about groundbreaking trends that every savvy investor needs to watch: Electrification: as ...
In this week’s podcast, Nucleus Wealth’s Chief Investment Officer, Damien Klassen and Head of Advice, Samuel Kerr take a hard look at the problems with Value investing. Value investing has had a really bad decade. Over the last 10 years, the MSCI World Value Index has returned approximately 50% ...
October is known as a month of heightened volatility, and this year it didn't disappoint. Returns swung from +3.5% to -3% before settling in the red at -1%. This is the third consecutive month of negative stock market returns, and while our tactical portfolios were not exempt, they all performed ...
Years after the COVID19 pandemic has subsided, excess mortality is still way higher than usual in countries all around the world. Suicides, cancer, COVID19 and heart disease are all running above average. In this week’s podcast, Nucleus Wealth’s Chief Investment Officer, Damien Klassen, delves into ...
This is the abridged version of last week's podcast, delving into the landscape of 3rd quarter earnings:
I've spoken about the next couple of reporting seasons being crucial in working out the path for stocks. Earnings have been coming in negative for the last few quarters, but forecasts imply an earnings boom.
In this week’s podcast, Nucleus Wealth’s Chief Investment Officer, Damien Klassen, and Head of Advice, Samuel Kerr, delve into the complex landscape of 3rd quarter earnings. The overall trend shows a downgrade in earnings forecasts, signalling a cautious approach by many companies. However, amidst ...
In this rapid insight episode, we look at the rise of weight-loss drugs. Don't sleep on this theme, there may be some dramatic investment implications. Targeting obesity, these drugs are not just a healthcare game changer but may also have a profound economic impact on the estimated 3% of global ...
One of the recent mega-trends in the healthcare space has been the evolution of a new class of weight-loss drugs that purport to be the magic pill that the pharmaceutical industry has been seeking to address the obesity epidemic. There are obvious implications for the stocks involved. And, there is ...
In this week’s podcast, Nucleus Wealth’s Chief Investment Officer, Damien Klassen, and Head of Advice, Samuel Kerr, revisited the tense relations with our largest trading partner. Prime Minister Albanese is in China this week. The Australia-China trade relationship has been fraught with tension, ...
In this week’s podcast, Nucleus Wealth’s Chief Investment Officer Damien Klassen, Senior Investment Analyst Radek Zeleny, and Head of Advice Samuel Kerr, delve into the fast-growing market of weight loss drugs, exploring the latest trends, breakthroughs, and market dynamics. We provide an in-depth ...
The conflict in the Middle East has caused oil prices to surge. This could lead to a cost-push inflation spiral: higher inflation --> higher wage demands --> higher inflation. Or, it could lead to demand destruction as higher fuel costs squeeze household budgets. For investors, working out ...
